[Podcast] Merck Marketing Expert Discusses AI in Oncology Care
In a recent episode of Life Science Marketing Radio, Chris Conner interviewed Hemal Somaiya, Global Brand Lead for Oncology at [...]
Mark Cuban Enters Convoluted PBM Market, Promises Lower Prescription Drug Prices
Two new groups have entered the pharmacy benefit manager (PBM) market: Mark Cuban and a coalition of employers. The Mark [...]
Eli Lilly CEO Shares Thoughts on How Medicare Pricing Measures Could Impact Innovation
Eli Lilly CEO David Ricks shared his thoughts on how policies intended to lower drug prices would negatively impact pharmaceutical [...]
Newly Launched Cerner Enviza Utilizes RWD to Advance R&D, Improve Patient Outcomes, and Reduce Healthcare Costs
Cerner has launched Cerner Enviza, an operating unit that will use real world data (RWD) to advance clinical research and improve [...]
Savana CEO and Founder Discusses Overcoming RWE Challenges and Ensuring Data Privacy
Savana CEO and Founder discussed challenges that arise when designing real world evidence (RWE) studies, including data privacy concerns, data [...]
RWE Brings Data Privacy Concerns and Solutions
The use of real world evidence (RWE) has put a spotlight on data privacy and regulatory concerns. Regulatory expert Jackie [...]
Investigators Use RWD to Identify Potential Alzheimer’s Drug
According to a new study using data from electronic health records (EHRs), bumetanide, a diuretic, could be used in patients [...]
RWD Study Finds Association Between High BMI and COVID-19 Risk
Researchers used Swedish real world data (RWD) to understand risk factors linked to poor COVID-19 outcomes. The investigators identified a [...]
IQVIA RWE Expert Discusses Trust, COVID-19, and FDA Framework
IQVIA’s Chirag Ghai recently shared his thoughts on real world evidence (RWE), its use in addressing brought by the COVID-19 [...]
Four Health Strategies Help Employers Reduce Costs
A new article highlights four approaches that can help forward-looking employers reduce the costs of healthcare. These strategies include advanced [...]
Whitepaper Highlights the Benefits of Digital Data Collection
Signant Health has published a whitepaper that compares digital data collection with manual methods. A growing number of clinical trial [...]
Three Decades of Democratic Drug Price Control Efforts Face Uncertainty
More than thirty years of drug price regulation efforts by Democrats are facing uncertainty as efforts to pass legislation allowing [...]
ISPOR Article on the Growing Wearable Market and New Applications in Healthcare
A recent article featured in Value & Outcomes Spotlight details the growing use of wearables. These tools can be an [...]
HealthVerity’s RWD Platform Informs Government Response to COVID-19
HealthVerity’s IPGE platform has been a critical source of real world data (RWD) for public health agencies throughout the COVID-19 [...]
Sumitomo Dainippon Pharma and BehaVR announce landmark deal for multiple virtual reality digital therapeutics
OSAKA , Japan and NASHVILLE, Tenn. Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan ; Representative Director, President and [...]
Register Now for Upcoming October Webinar on RWE in Regulatory Filings
Flatiron Health will hold a webinar detailing how real world evidence (RWE) can be used in regulatory findings. The webinar [...]
EURIPID Survey Shines Spotlight on Drug Price Transparency and Confidential Payer-Pharma Agreements
A recent article, published in Health Policy, highlights the use of confidential managed-entry agreements (MEAs) between payers and pharma throughout [...]
ISPOR Director Discusses Global Commitment to Improving HEOR
Director of Global Networks at the International Society for Pharmacoeconomics and Outcomes (ISPOR) Robert Selby discussed ISPOR’s worldwide initiative intended to [...]
Pear Launches PDT Digest, Highlights the Power of Digital Tools in Improving Patient Outcomes and Reducing Costs
Pear Therapeutics recently launched the Prescription Digital Therapeutics (PDT) Digest, intended to showcase the value of digital tools in improving [...]
ICER’s Final Evidence Report for Two Myasthenia Gravis Therapies Now Available
The Institute for Clinical and Economic Review (ICER) has published its final evidence report for two drugs used to treat [...]
Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch
Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch nmissakian Thu, 10/14/2021 - 16:30 [...]
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug’s outcomes trial
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug's outcomes trial aliu Mon, 10/18/2021 - [...]
Healthcare marketing firm Relevate Health unveils brand refresh to highlight digital focus
Healthcare marketing firm Relevate Health unveils brand refresh to highlight digital focus nmissakian Wed, 10/13/2021 - 16:53 Read the source [...]
A test of NICE’s resolve: clinical guidelines for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
The work of the UK’s HTA body, the National Institute for Health and Care Excellence (NICE), is often heatedly debated, [...]
Translating EU presence to US market success
Companies looking to replicate a drug’s EU market success in the US will face significant hurdles unless they are fully [...]